Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Mersana Therapeutics Inc
(NQ:
MRSN
)
1.570
+0.010 (+0.62%)
Streaming Delayed Price
Updated: 9:52 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mersana Therapeutics Inc
< Previous
1
2
3
4
5
Next >
MRSN Stock Earnings: Mersana Therapeutics Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
MRSN stock results show that Mersana Therapeutics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
MRSN Stock Earnings: Mersana Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
MRSN stock results show that Mersana Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 24, 2024
Via
Benzinga
The Analyst Verdict: Mersana Therapeutics In The Eyes Of 5 Experts
March 19, 2024
Via
Benzinga
Expert Outlook: Mersana Therapeutics Through The Eyes Of 5 Analysts
February 29, 2024
Via
Benzinga
A Preview Of Mersana Therapeutics's Earnings
February 27, 2024
Via
Benzinga
What To Know About Citigroup's Upgrade of Mersana Therapeutics
December 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 15, 2024
Via
Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.
Via
Benzinga
A Preview Of Mersana Therapeutics's Earnings
November 06, 2023
Via
Benzinga
Why Mersana Therapeutics Stock Is Plunging Today?
July 27, 2023
Mersana Therapeutics Inc (NASDAQ: MRSN) shares are sinking after the company announced that the UPLIFT clinical trial of upifitamab rilsodotin (UpRi) did
Via
Benzinga
Hormel Foods Reports Upbeat Earnings, Joins Pure Storage, Okta, Papa John's International And Other Big Stocks Moving Higher On Thursday
February 29, 2024
U.S. stocks were higher, with the Nasdaq Composite gaining around 50 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024
January 22, 2024
Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.
Via
InvestorPlace
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...
Via
PressReach
What 4 Analyst Ratings Have To Say About Mersana Therapeutics
June 16, 2023
Via
Benzinga
Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 18, 2024
Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...
Via
Benzinga
How To Invest In The Healthcare Sector
August 19, 2023
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how...
Via
Talk Markets
Dow Dips Over 200 Points; McDonald's Tops Q2 Expectations
July 27, 2023
U.S. stocks turned lower toward the end of trading on Thursday, with the Dow Jones falling more than 200 points . The Dow traded down 0.59% to 35,310.03 while the NASDAQ fell 0.44% to 14,064.61. The...
Via
Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 28, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 27, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
July 27, 2023
During Thursday, 56 stocks hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
July 28, 2023
Via
Benzinga
Nasdaq Up 1%; Meta Shares Surge Following Upbeat Results
July 27, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Thursday. Following the market opening Thursday, the Dow traded up 0.15% to 35,573.49 while the NASDAQ...
Via
Benzinga
Dow Jumps 100 Points; US GDP Rises 2.4% In Q2
July 27, 2023
U.S. stocks traded higher this morning, following the release of major economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.28% to 35,620.79 while the NASDAQ rose...
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 27, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Via
Benzinga
Cancer Drug Trials Put On Hold After Patients Died
June 17, 2023
Recent reports from two drug companies that had been conducing separate clinical trials to evaluate cancer treatments reveal that the trials were halted due to the deaths of six participants, including...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
June 16, 2023
Via
Benzinga
NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
June 16, 2023
Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.